ATE195422T1 - Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen - Google Patents
Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungenInfo
- Publication number
- ATE195422T1 ATE195422T1 AT93923615T AT93923615T ATE195422T1 AT E195422 T1 ATE195422 T1 AT E195422T1 AT 93923615 T AT93923615 T AT 93923615T AT 93923615 T AT93923615 T AT 93923615T AT E195422 T1 ATE195422 T1 AT E195422T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- piperazine derivatives
- treat cognitive
- cognitive diseases
- date
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929223153A GB9223153D0 (en) | 1992-11-05 | 1992-11-05 | Piperazine derivatives |
| PCT/GB1993/002197 WO1994009780A1 (en) | 1992-11-05 | 1993-10-25 | Use of piperazine derivatives for the treatment of cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE195422T1 true ATE195422T1 (de) | 2000-09-15 |
Family
ID=10724559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93923615T ATE195422T1 (de) | 1992-11-05 | 1993-10-25 | Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5827847A (de) |
| EP (1) | EP0877612B1 (de) |
| JP (1) | JP3238153B2 (de) |
| AT (1) | ATE195422T1 (de) |
| AU (1) | AU682155B2 (de) |
| CA (1) | CA2148593C (de) |
| DE (1) | DE69329252T2 (de) |
| DK (1) | DK0877612T3 (de) |
| ES (1) | ES2149216T3 (de) |
| GB (1) | GB9223153D0 (de) |
| GR (1) | GR3034400T3 (de) |
| HU (1) | HUT72049A (de) |
| LV (1) | LV12734B (de) |
| MX (1) | MX9306879A (de) |
| PT (1) | PT877612E (de) |
| TW (1) | TW252043B (de) |
| WO (1) | WO1994009780A1 (de) |
| ZA (1) | ZA937827B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0710481A1 (de) * | 1994-11-02 | 1996-05-08 | Duphar International Research B.V | Verwendung von Flesinoxan zur Wahrnehmungssteigerung |
| US6271234B1 (en) * | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2355502A1 (fr) * | 1976-06-23 | 1978-01-20 | Roussel Uclaf | Application a titre de medicaments d'un derive de la piperazine et de ses sels |
| US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
| GB2222768B (en) * | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
| GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US4902687A (en) * | 1989-03-27 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| NZ233398A (en) * | 1989-04-22 | 1991-12-23 | American Home Prod | Aryl- or heteroaryl-substituted piperazine derivatives and pharmaceutical compositions |
| ATE179973T1 (de) * | 1989-04-22 | 1999-05-15 | Wyeth John & Brother Ltd | Piperazin-derivate |
| EP0398413A1 (de) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | 3,4-Dehydropiperidin-Derivate mit psychotroper Wirkung |
| DK0510068T3 (da) * | 1990-01-11 | 1999-10-25 | Upjohn Co | Nye 6,7,8,9-tetrahydro-3H-benz(e)indol-heterocycler med virkning på centralnervesystemet |
| GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
| IL101722A (en) * | 1991-05-02 | 1996-05-14 | Wyeth John & Brother Ltd | History of piperazine, their preparation and pharmaceutical preparations containing them |
| DE4135551A1 (de) * | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
-
1992
- 1992-11-05 GB GB929223153A patent/GB9223153D0/en active Pending
-
1993
- 1993-10-21 ZA ZA937827A patent/ZA937827B/xx unknown
- 1993-10-25 JP JP51081394A patent/JP3238153B2/ja not_active Expired - Fee Related
- 1993-10-25 PT PT93923615T patent/PT877612E/pt unknown
- 1993-10-25 EP EP93923615A patent/EP0877612B1/de not_active Expired - Lifetime
- 1993-10-25 DK DK93923615T patent/DK0877612T3/da active
- 1993-10-25 AT AT93923615T patent/ATE195422T1/de not_active IP Right Cessation
- 1993-10-25 AU AU53421/94A patent/AU682155B2/en not_active Ceased
- 1993-10-25 US US08/428,093 patent/US5827847A/en not_active Expired - Fee Related
- 1993-10-25 ES ES93923615T patent/ES2149216T3/es not_active Expired - Lifetime
- 1993-10-25 CA CA002148593A patent/CA2148593C/en not_active Expired - Fee Related
- 1993-10-25 HU HU9501290A patent/HUT72049A/hu unknown
- 1993-10-25 WO PCT/GB1993/002197 patent/WO1994009780A1/en active IP Right Grant
- 1993-10-25 DE DE69329252T patent/DE69329252T2/de not_active Expired - Fee Related
- 1993-10-26 TW TW082108882A patent/TW252043B/zh active
- 1993-11-04 MX MX9306879A patent/MX9306879A/es not_active IP Right Cessation
-
2000
- 2000-09-13 GR GR20000402090T patent/GR3034400T3/el not_active IP Right Cessation
-
2001
- 2001-07-04 LV LVP-01-102A patent/LV12734B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2148593A1 (en) | 1994-05-11 |
| JPH08502743A (ja) | 1996-03-26 |
| DE69329252D1 (de) | 2000-09-21 |
| GB9223153D0 (en) | 1992-12-16 |
| EP0877612A1 (de) | 1998-11-18 |
| HUT72049A (en) | 1996-03-28 |
| DE69329252T2 (de) | 2001-03-29 |
| GR3034400T3 (en) | 2000-12-29 |
| AU5342194A (en) | 1994-05-24 |
| AU682155B2 (en) | 1997-09-25 |
| WO1994009780A1 (en) | 1994-05-11 |
| HU9501290D0 (en) | 1995-06-28 |
| US5827847A (en) | 1998-10-27 |
| ZA937827B (en) | 1995-04-21 |
| JP3238153B2 (ja) | 2001-12-10 |
| TW252043B (de) | 1995-07-21 |
| LV12734B (en) | 2002-01-20 |
| LV12734A (en) | 2001-10-20 |
| ES2149216T3 (es) | 2000-11-01 |
| DK0877612T3 (da) | 2000-10-09 |
| MX9306879A (es) | 1995-01-31 |
| EP0877612B1 (de) | 2000-08-16 |
| CA2148593C (en) | 2005-12-06 |
| PT877612E (pt) | 2000-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE163545T1 (de) | Verwendung von adamantan-derivaten zur behandlung von tinnitus | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| ATE249228T1 (de) | Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia | |
| DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| ATE168007T1 (de) | Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole | |
| DE69424009T2 (de) | Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst | |
| ATE241981T1 (de) | Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks | |
| ATE190839T1 (de) | Verwendung von prodelphidinen zur behandlung von arthrose | |
| DE69315085T2 (de) | 1,4-disubstituierte piperazine zur behandlung von asthma und entzündungen der atemwege | |
| ATE148109T1 (de) | Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids | |
| ATE195422T1 (de) | Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen | |
| ATE223379T1 (de) | N-aryloxyethylaminderivate zur behandlung der depression | |
| DE69400702D1 (de) | N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten | |
| DE69227899D1 (de) | Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen | |
| DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| DE69421705T2 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
| DE69619088T2 (de) | Quinoxalin-Derivate zur Behandlung von Tinnitus | |
| DE59709081D1 (de) | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit | |
| ATE136217T1 (de) | Verwendung von imino-derivaten von etianaldehyd zur herstellung eines arzneimittels zur behandlung des bluthochdrucks | |
| DE59409813D1 (de) | Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen | |
| DE59504374D1 (de) | Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen | |
| ATE177637T1 (de) | Triazolochinazoline zur behandlung zentralnervöser erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |